Vokes, E E <br/><br/>
A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.  [electronic resource] 

 -  Seminars in oncology  Oct 1994 
 - 79-83; discussion 83-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0093-7754 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Agranulocytosis--chemically induced<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Bone Marrow--drug effects<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cisplatin--administration & dosage<br/>Cohort Studies<br/>Drug Administration Schedule<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Leucovorin--administration & dosage<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Remission Induction<br/>Vinblastine--administration & dosage<br/>Vinorelbine